Literature DB >> 28143891

Genome-wide methylation profiles in coronary artery ectasia.

Tzu-Pin Lu1, Nai-Chen Chuang1, Chin-Yu Cheng2, Cheng-An Hsu2, Yi-Chih Wang3, Yen-Hong Lin3, Jen-Kuang Lee3, Cho-Kai Wu3, Juey-Jen Hwang3, Lian-Yu Lin3, Shih-Fan Sherri Yeh4,5, Kuo-Liang Chien1, Jyh-Ming Jimmy Juang6.   

Abstract

Coronary artery ectasia (CAE) is a disease characterized by abnormally dilated coronary arteries. The mechanism of CAE remains unclear, and its treatment is limited. Previous studies have shown that risk factors for CAE were related to changes in DNA methylation. However, no systematic investigation of methylation profiles has been performed. Therefore, we compared methylation profiles between 12 CAE patients and 12 propensity-matched individuals with normal coronary arteries using microarrays. Wilcoxon's rank sum tests revealed 89 genes with significantly different methylation levels (P<0.05 and Δβ > |0.1|). Functional characterization using the DAVID database and gene set enrichment analysis indicated that these genes were involved in immune and inflammatory responses. Of these genes 6 were validated in 29 CAE patients and 87 matched individuals with CAE, using pyro-sequencing. TLR6 and NOTCH4 showed significant differences in methylation between the two groups, and lower protein levels of toll-like receptor 6 (TLR6) were detected in CAE patients. In conclusion, this genome-wide analysis of methylation profiles in CAE patients showed that significant changes in both methylation and expression of TLR6 deserve further study to elucidate their roles in CAE.
© 2017 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.

Entities:  

Keywords:  TLR6; coronary artery ectasia; methylation; microarray

Mesh:

Substances:

Year:  2017        PMID: 28143891     DOI: 10.1042/CS20160821

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  5 in total

Review 1.  Translational Perspective on Epigenetics in Cardiovascular Disease.

Authors:  Pim van der Harst; Leon J de Windt; John C Chambers
Journal:  J Am Coll Cardiol       Date:  2017-08-01       Impact factor: 24.094

Review 2.  Inflammatory Biomarkers in Coronary Artery Ectasia: A Systematic Review and Meta-Analysis.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Dimitrios Kazantzis; Jorge Sanz-Sánchez; Sotiria G Giotaki; Konstantinos Raisakis; Andreas Kaoukis; Charalampos Kossyvakis; Gerasimos Deftereos; Bernhard Reimers; Dimitrios Avramides; Gerasimos Siasos; Michael Cleman; George Giannopoulos; Alexandra Lansky; Spyridon Deftereos
Journal:  Diagnostics (Basel)       Date:  2022-04-19

3.  Plasma Big Endothelin-1 Level Predicted 5-Year Major Adverse Cardiovascular Events in Patients With Coronary Artery Ectasia.

Authors:  Zhongxing Cai; Haoyu Wang; Sheng Yuan; Dong Yin; Weihua Song; Kefei Dou
Journal:  Front Cardiovasc Med       Date:  2021-11-29

4.  Development and Validation of a Nomogram for Predicting the Risk of Adverse Cardiovascular Events in Patients with Coronary Artery Ectasia.

Authors:  Zhongxing Cai; Yintang Wang; Luqi Li; Haoyu Wang; Chenxi Song; Dong Yin; Weihua Song; Kefei Dou
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-14

5.  Effect of type 2 diabetes on coronary artery ectasia: smaller lesion diameter and shorter lesion length but similar adverse cardiovascular events.

Authors:  Zhongxing Cai; Luqi Li; Haoyu Wang; Sheng Yuan; Dong Yin; Weihua Song; Kefei Dou
Journal:  Cardiovasc Diabetol       Date:  2022-01-19       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.